Ticker Details
ADC Therapeutics SA
IPO Date:	May 18, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$507.9M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.37 | 3.77%
Avg Daily Range (30 D):	$0.11 | 2.81%
Avg Daily Range (90 D):	$0.12 | 3.04%

Institutional Daily Volume
Avg Daily Volume:	.46M
Avg Daily Volume (30 D):	.65M
Avg Daily Volume (90 D):	.91M

Trade Size
Avg Trade Size (Sh.):	141
Avg Trade Size (Sh.) (30 D):	111
Avg Trade Size (Sh.) (90 D):	120

Institutional Trades
Total Institutional Trades:	326
Avg Institutional Trade:	$1.37M
Avg Institutional Trade (30 D):	$1.8M
Avg Institutional Trade (90 D):	$1.79M
Avg Institutional Trade Volume:	.19M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.23M
Avg Closing Trade (30 D):	$4.4M
Avg Closing Trade (90 D):	$2.21M
Avg Closing Volume:	498.04K

News

Jan 13, 2026 @ 9:58 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Dec 30, 2025 @ 5:59 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Dec 30, 2025 @ 5:50 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Jun 26, 2025 @ 3:44 PM The $900 Billion Question: Who Will Deliver the Ne... Source: Prnewswire

May 12, 2025 @ 5:00 PM Blood Cancer Treatment Market Sees Accelerated Gro... Source: Delveinsight

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-1.41	$-.3	$-.5
Diluted EPS	$-1.41	$-.3	$-.5
Revenue	$75.21M	$16.43M	$18.84M
Gross Profit
Net Income / Loss	$-166.94M	$-40.97M	$-56.65M
Operating Income / Loss	$-136.02M	$-30.97M	$-44.15M
Cost of Revenue
Net Cash Flow	$-39.53M	$-29.82M	$69.86M
PE Ratio

Splits
May 10, 2005	1:7